Expression pattern of long non-coding RNAs MALAT1 and MEG3 in COVID-19 patients
Description
CONCLUSIONS: MALAT1 levels are higher, whereas MEG3 levels are lower in COVID-19 patients. Both are linked to disease severity and mortality and could emerge as predictive biomarkers for COVID-19 severity and therapeutic targets.
